Pulmonary Hemodynamic Responses to Inhaled NO in Chronic Heart Failure Depend on PDE5 G(-1142)T Polymorphism


To evaluate the vasoconstrictor component of PH in CHF by investigating the hemodynamic response to inhaled nitric oxide (iNO) and to determine whether this response was influenced by the phosphodiesterase 5 gene (PDE5) G(1142)T polymorphism. CHF patients underwent right heart catheterization at rest and after 20 ppm of iNO and plasma cGMP and PDE5 G(1142)T polymorphism determinations. Of the 72 included CHF patients (mean age, 53±1 years; mean left ventricular ejection fraction, 29±1%; and mean pulmonary artery pressure, 25.5±1.3 mmHg), 54% had ischemic heart disease. Proportions of patients with the TT, GT, and GG genotypes were 39%, 42% and 19% respectively. Baseline hemodynamic characteristics were not significantly different across PDE5 genotype groups, although pulmonary capillary wedge pressure (PCWP) tended to be lower in the TT group (P=0.09). Baseline plasma cGMP levels were significantly lower in the TT than in the GG and GT patients. With iNO, PVR diminished in TT (-33%) but not GG (-1.6%) or GT (0%) patients (P=0.002); and PCWP increased more in TT than in GT (P<0.05) or GG (P<0.003) patients. The PDE5 G(-1142) polymorphism is therefore a major contributor to the iNO-induced PVR decrease in CHF.

Read the full article online


Heart Arrest/ Block/ Defects/ Diseases/ Failure/ Rate/ Infarction
Hemodynamics and Hypertension and Hypertrophy
Nitric Oxide and Nitric Oxide Synthase


Thibaud Damy, Pierre-François Lesault, Soulef Guendouz, Saadia Eddahibi, Ly Tu, Elisabeth Marcos, Aziz Guellich, Jean-Luc Dubois-Randé, Emmanuel Teiger, Luc Hittinger, Serge Adnot

Published in:

Pulmonary Circulation Vol 1: No 3 cover image

September 2011

Pulmonary Circulation Vol 1: No 3

View this journal

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI